Innovent Biologics Inc Sustainability Reports
Innovent Biologics, Inc. is a biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative therapeutics for cancer, cardiovascular, metabolic, autoimmune, and eye diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 25490058ONL9SCIE1R22
FIGI: BBG00M8832C4
14 reports from 2018 to 2025
